Osteoarthritis associated with estrogen deficiency
Citations Over TimeTop 10% of 2009 papers
Abstract
Osteoarthritis (OA) affects all articular tissues and finally leads to joint failure. Although articular tissues have long been considered unresponsive to estrogens or their deficiency, there is now increasing evidence that estrogens influence the activity of joint tissues through complex molecular pathways that act at multiple levels. Indeed, we are only just beginning to understand the effects of estrogen deficiency on articular tissues during OA development and progression, as well as on the association between OA and osteoporosis. Estrogen replacement therapy and current selective estrogen receptor modulators have mixed effectiveness in preserving and/or restoring joint tissue in OA. Thus, a better understanding of how estrogen acts on joints and other tissues in OA will aid the development of specific and safe estrogen ligands as novel therapeutic agents targeting the OA joint as a whole organ.
Related Papers
- → Inter-Individual Variation in Response to Estrogen in Human Breast Explants(2020)9 cited
- → Estrogen Up-regulates ATBF1 Transcription but Causes Its Protein Degradation in Estrogen Receptor-α-positive Breast Cancer Cells(2011)30 cited
- → Involvement of estrogen receptors α and β in the regulation of cervical permeability(2000)32 cited
- → Estrogen Actions in the Brain(2002)8 cited
- Effects of estrogen on estrogen receptors in myocardium of ovariectomized female rats(2008)